IP Library Granted Patent US 10,012,627
Granted Patent B2
US 10,012,627 · App. 14/777,264 · Granted Jul 3, 2018

Determining stereoisomeric excess, concentration and absolute configuration

Inventors: Christian Wolf (Arlington, VA); Peng Zhang (Arlington, VA)
Assignee: Georgetown University
G01N31/10G01N21/19
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,012,627
App. No.
14/777,264
Granted
Jul 3, 2018
Kind
B2
Abstract

The present invention is directed to analytical methods for determining the concentration, and/or stereoisomeric excess, and/or absolute configuration of chiral analytes in a sample.

Claims (25)

1. An analytical method comprising:

providing a sample potentially containing a chiral analyte that can exist in stereoisomeric forms;

providing a racemic mixture of a probe having the formula A m -MR n —Y o , wherein:

each A is independently a chiral stereodynamic ligand that undergoes rapid stereoisomeric interconversion at room temperature,

M is a metal,

each R is independently a metal coordinating ligand,

each Y is independently a displaceable ligand,

m is an integer from 1 to 6, and

n and o are each independently an integer from 0 to 6, wherein the sum of m, n, and o is from 1 to 6;

contacting the sample with the racemic mixture under conditions effective to form probe-analyte complexes; and

determining, based on the probe-analyte complexes that form, the stereoisomeric excess of the analyte in the sample and/or the concentration of the analyte in the sample.

2. The analytical method according to claim 1 , wherein A is selected from the group consisting of 1,1′-bis(diphenylphosphino)ferrocene (DPPF), 2,2′-bis(diphenylphosphino)diphenyl ether (BDPDE), 2,2′-bis(diphenylphosphino)-1,1′-biphenyl (BIPHEP), BIPHOS, 2,2′-diaminobiphenyls, 2,2′-dihydroxybiphenyls, and analogues of each of the preceding compounds.

3. The analytical method according to claim 1 , wherein M is selected from the group consisting of palladium, magnesium, boron, aluminum, copper, zinc, iron, cobalt, nickel, platinum, gold, titanium, vanadium, manganese, chromium and cobalt.

4. The analytical method according to claim 3 , wherein M is Pd(II).

5. The analytical method according to claim 1 , wherein each Y is independently selected from the group consisting of H, OH, NH 2 , NCCH 3 , CF 3 SO 3 − , alkyls, alkenyls, alkynyls, halogens, halides, halogen-containing anions, haloalkyls, haloalkenyls, hydroxyls, alcohols, hydrides, carbonyls, aldehydes, carbonate esters, carboxylates, carboxyls, esters, alkoxyls, alkoxides, ethers, hemiacetals, hemiketals, acetals, ketals, orthoesters, orthocarbonate esters, amides, amines, imines, imides, azides, diimides, cyanates, cyanides, nitrates, nitriles, nitrites, nitrosos, pyridyls, thiols, thioethers, disulfides, sulfoxides, sulfones, sulfonates, thiocyanates, thiones, phosphines, phosphoric acids, phosphates, aryls, heteroaryls, arylalkyls, heterocycles, cycloalkyls, cycloalkenyls, and acyls.

6. The analytical method according to claim 1 , wherein the probe is selected from the group consisting of

7. The analytical method according to claim 1 , wherein the analyte is a compound selected from the group consisting of amines, alcohols, amino alcohols, carboxylic acids, amino acids, thiols, aldehydes, ketones, amides, esters, and any combination thereof.

8. The analytical method according to claim 7 , wherein the analyte is a diamine or an amino alcohol.

9. The analytical method according to claim 1 , wherein the stereoisomeric excess of the probe-analyte complexes is determined.

10. The analytical method according to claim 9 , wherein the analyte is a reaction product and the stereoselectivity of the reaction is determined by determining the stereoisomeric excess of the analyte.

11. The analytical method according to claim 1 , wherein the concentration of the probe-analyte complexes is determined.

12. The analytical method according to claim 11 , wherein the analyte is a reaction product and the yield of the reaction is determined by determining the concentration of the analyte.

13. The analytical method according to claim 1 , wherein the stereoisomeric excess of the probe-analyte complexes and the concentration of the probe-analyte complexes are both determined.

14. The analytical method according to claim 13 further comprising:

determining the individual concentration of any particular stereoisomers present in the sample based on the determined concentration of the analyte and the determined stereoisomeric excess.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 2, 2018
From: WOLF, CHRISTIAN; ZHANG, PENG
To: GEORGETOWN UNIVERSITY
Reel/Frame 045698/0329 →
CONFIRMATORY LICENSE Recorded Dec 4, 2015
From: GEORGETOWN UNIVERSITY
To: NATIONAL SCIENCE FOUNDATION
Reel/Frame 037217/0954 →
Continuity (4)
Provisional Application 61903360 · Nov 12, 2013
Provisional Application 61902204 · Nov 9, 2013
Provisional Application 61791832 · Mar 15, 2013
Related Publication 20160011156A1 · Jan 14, 2016
Cited By (1)
US 12,486,293